Trial Profile
Randomized Multicenter Phase II Trial of S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy After Curative Resection of Stage II-IV(M0) Gastric Cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2020
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 04 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Sep 2011 New trial record